Bristol-Myers Squibb Company
US ˙ NYSE ˙ US1101221083

SecurityBMY / Bristol-Myers Squibb Company
InstitutionIntellectus Partners, LLC
Latest Disclosed Ownership18,796 shares
Latest Disclosed Value $ 1,139,950
Intellectus Partners, LLC reports 0.04% increase in ownership of BMY / Bristol-Myers Squibb Company

On April 10, 2026 - Intellectus Partners, LLC filed a 13F-HR form disclosing ownership of 18,796 shares of Bristol-Myers Squibb Company (US:BMY) valued at $1,139,977 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 18,788 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.04% during the quarter. The current value of the position is $1,028,517 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 18,796 8 0.04 1,140 12.44 0.2327
2026-02-10 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 18,788 -392 -2.04 1,013 17.11 0.1958
2025-11-12 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 19,180 -7,092 -26.99 865 -28.87 0.1676
2025-08-05 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 26,272 -682 -2.53 1,216 -25.99 0.2626
2025-04-11 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 26,954 -1,544 -5.42 1,644 1.99 0.4055
2025-02-07 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 28,498 -1,494 -4.98 1,612 3.87 0.3568
2024-11-06 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 29,992 -1,343 -4.29 1,552 19.22 0.3966
2024-07-18 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 31,335 -6,253 -16.64 1,301 -36.16 0.3552
2024-05-03 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 37,588 -138 -0.37 2,038 5.32 0.5360
2024-02-05 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 37,726 574 1.55 1,936 -10.25 0.5586
2023-10-25 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 37,152 -935 -2.45 2,156 -11.46 0.6822
2023-07-31 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 38,087 -679 -1.75 2,436 -9.34 0.7310
2023-05-04 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 38,766 -180 -0.46 2,687 -4.14 0.8483
2023-02-02 2022-12-31 13F Bristol Myers Squibb Equity 110122108 38,946 -223 -0.57 2,802 0.61 0.9755
2022-11-14 2022-09-30 13F Bristol Myers Squibb Equity 110122108 39,169 4,062 11.57 2,785 2.31 0.9905
2022-08-12 2022-06-30 13F Bristol Myers Squibb Common Stock 110122108 35,107 -1,055 -2.92 2,722 2.33 0.9352
2022-05-16 2022-03-31 13F Bristol Myers Squibb Common Stock 110122108 36,162 4,749 15.12 2,660 35.78 0.7940
2022-02-14 2021-12-31 13F Bristol Myers Squibb Common Stock 110122108 31,413 -1,113 -3.42 1,959 0.93 0.4994
2021-11-16 2021-09-30 13F Bristol Myers Squibb Equity 110122108 32,526 -887 -2.65 1,941 -13.08 0.4698
2021-08-13 2021-06-30 13F Bristol Myers Squibb Equity 110122108 33,413 1,773 5.60 2,233 10.93 0.5035
2021-05-17 2021-03-31 13F Bristol Myers Squibb Equity 110122108 31,640 744 2.41 2,013 4.19 0.5529
2021-02-18 2020-12-31 13F/A-1 Bristol Myers Squibb Common Stock 110122108 30,896 81 0.26 1,932 3.98 0.5782
2021-02-12 2020-12-31 13F Bristol Myers Squibb Common Stock 110122108 4,000 -26,815 1,932 574,440.9459
2020-11-16 2020-09-30 13F Bristol Myers Squibb Common Stock 110122108 30,815 3,638 13.39 1,858 16.27 0.7020
2020-08-14 2020-06-30 13F Bristol Myers Squibb Equity 110122108 27,177 -3,228 -10.62 1,598 -5.72 0.6194
2020-05-14 2020-03-31 13F Bristol Myers Squibb Equity 110122108 30,405 -2,473 -7.52 1,695 -19.67 0.8076
2020-01-24 2019-12-31 13F Bristol Myers Squibb Common Stock 110122108 32,878 19,878 152.91 2,110 220.18 0.8585
2019-10-10 2019-09-30 13F Bristol Myers Squibb Equity 110122108 13,000 505 4.04 659 16.23 0.2896
2019-08-08 2019-06-30 13F Bristol Myers Squibb Common Stock 110122108 12,495 11,883 1,941.67 567 1,855.17 0.2453
2019-05-15 2019-03-31 13F Bristol Myers Squibb Equity 110122108 612 0 0.00 29 -9.37 0.0125
2019-02-14 2018-12-31 13F Bristol Myers Squibb COM 110122108 612 -3,383 -84.68 32 -87.10 0.0219
2018-11-15 2018-09-30 13F Bristol Myers Squibb Equity 110122108 3,995 112 2.88 248 15.35 0.0866
2018-08-14 2018-06-30 13F Bristol Myers Squibb Equity 110122108 3,883 0 0.00 215 -12.60 0.0784
2018-05-15 2018-03-31 13F Bristol Myers Squibb Equity 110122108 3,883 0 0.00 246 3.36 0.0845
2018-02-13 2017-12-31 13F Bristol Myers Squibb Equity 110122108 3,883 -80 -2.02 238 -5.93 0.0888
2017-11-14 2017-09-30 13F Bristol Myers Squibb Equity 110122108 3,963 0 0.00 253 14.48 0.1048
2017-08-15 2017-06-30 13F Bristol Myers Squibb Equity 110122108 3,963 80 2.06 221 4.74 0.0995
2017-05-08 2017-03-31 13F Bristol Myers Squibb Equity 110122108 3,883 0 0.00 211 -7.05 0.1072
2017-02-14 2016-12-31 13F Bristol Myers Squibb Equity 110122108 3,883 3,883 227 0.1181
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.